| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/11/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 50k | $30.03 | $1.5M | | 07/11/2023 |
| 07/11/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Exercise | Stock Option (Right to Buy) | 50k | $3.50 | $175k | | 07/11/2023 |
| 05/04/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 37.6k | $31.36 | $1.2M | | 05/04/2023 |
| 05/04/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 12.1k | $31.76 | $385.3k | | 05/04/2023 |
| 05/04/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 300 | $32.93 | $9.9k | | 05/04/2023 |
| 05/04/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Exercise | Stock Option (Right to Buy) | 50k | $3.50 | $175k | | 05/04/2023 |
| 03/03/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 3k | $27.19 | $81.6k | | 03/02/2023 |
| 03/03/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Exercise | Stock Option (Right to Buy) | 3k | $3.50 | $10.5k | | 03/02/2023 |
| 03/02/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Exercise | Stock Option (Right to Buy) | 47k | $3.50 | $164.5k | | 03/02/2023 |
| 03/02/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 47k | $27.11 | $1.3M | | 03/02/2023 |
| 02/07/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 42.1k | $33.04 | $1.4M | | 02/06/2023 |
| 02/07/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 7.9k | $33.57 | $266.6k | | 02/06/2023 |
| 02/07/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Exercise | Stock Option (Right to Buy) | 50k | $3.50 | $175k | | 02/06/2023 |
| 02/06/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Grant | Stock Option (Right to Buy) | 243k | $34.41 | $8.4M | | 02/06/2023 |
| 02/06/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Grant | Restricted Stock Units | 61.8k | $0.00 | $0 | | 02/06/2023 |
| 01/05/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Exercise | Stock Option (Right to Buy) | 50k | $3.50 | $175k | | 01/05/2023 |
| 01/05/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 500 | $30.73 | $15.4k | | 01/05/2023 |
| 01/05/2023 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 49.5k | $29.93 | $1.5M | | 01/05/2023 |
| 01/03/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Grant | Common Stock | 165 | $0.00 | $0 | | 01/03/2023 |
| 01/03/2023 | REGENERON PHARMACEUTICALS, INC. | REGN | Grant | Non-Qualified Stock Option (right to buy) | 1.9k | $725.89 | $1.4M | | 01/03/2023 |
| 12/28/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 181 | $707.87 | $128.1k | | 12/28/2022 |
| 12/28/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 1 | $709.92 | $709.9 | | 12/28/2022 |
| 12/28/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 679 | $710.63 | $482.5k | | 12/28/2022 |
| 12/28/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 100 | $711.95 | $71.2k | | 12/28/2022 |
| 12/28/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 1.2k | $713.66 | $855k | | 12/28/2022 |
| 12/28/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 1k | $714.61 | $730.3k | | 12/28/2022 |
| 12/28/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 2.3k | $715.48 | $1.6M | | 12/28/2022 |
| 12/28/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 311 | $716.08 | $222.7k | | 12/28/2022 |
| 12/28/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 2.1k | $374.12 | $802.5k | | 12/28/2022 |
| 12/28/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Exercise | Non-Qualified Stock Option (right to buy) | 3.6k | $482.68 | $1.7M | | 12/28/2022 |
| 12/09/2022 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 5.1k | $27.09 | $139.4k | | 12/09/2022 |
| 12/09/2022 | Cerevel Therapeutics Holdings, Inc. | CERE | Exercise | Stock Option (Right to Buy) | 50k | $3.50 | $175k | | 12/09/2022 |
| 12/09/2022 | Cerevel Therapeutics Holdings, Inc. | CERE | Sale | Common Stock | 44.9k | $26.62 | $1.2M | | 12/09/2022 |
| 09/06/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 1k | $583.16 | $609.4k | | 09/06/2022 |
| 09/06/2022 | REGENERON PHARMACEUTICALS, INC. | REGN | Sale | Common Stock | 602 | $584.57 | $351.9k | | 09/06/2022 |
|